“PARP Inhibitors in Newly Diagnosed or Recurrent Ovarian Cancer Maintenance Therapy: Evidence of Efficacy and Safety from Randomized Controlled Trials”. Biomedical Research and Therapy 10, no. 12 (December 31, 2023): 6090–6102. Accessed November 15, 2024. https://preservation.bmrat.org/index.php/BMRAT/article/view/851.